Evidence map›Paper›PMID 10766301›Full record

ArticleVirus genes2000

The exchange of cognate TATA boxes results in a corresponding change in the strength of two HSV-1 early promoters.

P T Lieu, N T Pande, M K Rice, E K Wagner

Abstract read
PubMed Publisher
In one paragraph

Article in Virus genes, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

P T LieuDepartment of Molecular Biology and Biochemistry, University of California Irvine, 92697, USA.
N T Pande
M K Rice
E K Wagner

Funding

CONTROL OF VIRAL RNA SYNTHESIS IN HERPESVIRUS INFECTIONR01CA011861 · NCI · UNIVERSITY OF CALIFORNIA IRVINE · PI OSBORNE, TIMOTHY F · 1985 to 2005
$1.9M
LATENCY IN HERPESVIRUS INFECTIONS OF CELLS &TISSUESR01AI006246 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BLOOM, DAVID C · 1985 to 1998
–
LATENCY IN HERPESVIRUS INFECTIONS OF CELLS AND TISSUESR37AI006246 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI STEVENS, JACK G · 1994 to 1995
–
CONTROL OF VIRAL RNA SYNTHESIS IN HERPESVIRUS INFECTIONR37CA011861 · NCI · UNIVERSITY OF CALIFORNIA IRVINE · PI WAGNER, EDWARD K · 1988 to 1995
–
NCI NIH HHS CA11861NIAID NIH HHS AI06246
6 · The paper itself

Abstract

Previous analysis of two Herpes Simplex Virus Type-1 (HSV-1) promoters controlling expression of mRNA encoding early genes (U(L)37 and U(L)50) showed that the U(L)50 (dUTPase) promoter is at least 6-fold stronger both in its normal genomic location and in the non-essential gC locus. In the present report we demonstrate that the TATA element of either promoter is the major determinant of promoter strength. When the U(L)37 TATA element (CGTATAAC) was mutated with two base changes to the U(L)50 TATA sequence (CATAAAAC) in recombinant viruses, the activity of the U(L)37 promoter was increased to that of the U(L)50 promoter. Conversely, when the U(L)50 TATA element was changed to that of the U(L)37 promoter, U(L)50 promoter activity was reduced to the level of the U(L)37 promoter. In addition, we investigated the spacing of the TATA box with respect to upstream promoter elements. We found that re-positioning the U(L)37 TATA box to a location equivalent to that of the U(L)50 promoter relative to the transcript start site; i.e. three bases upstream of its cognate location, significantly diminished activity. Substitution of the U(L)50 TATA box at the new position could only partially restore promoter activity. Thus, we also conclude that the spacing of TATA elements vis-à-vis upstream promoter elements is also a critical determinant of promoter strength.

Indexed as

AnimalsChlorocebus aethiopsFibroblastsHerpesvirus 1, HumanMutagenesis, Site-DirectedPromoter Regions, GeneticRabbitsRNA, MessengerTATA BoxVero CellsRNA, Messenger

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.